These data have suggested that ATRs can effectively alleviate RA by regulating Th17/Treg balance, FLS mobility and oxidative stress via suppressing PI3K/AKT/mTOR and AKT/RSK2 signaling pathways while activating p62/Nrf2 signaling. The gene discussed is RPS6KA3; the disease is rheumatoid arthritis.